Gralise for Spine Surgery Pain (GRASSP): A Partially Enriched, Placebo Controlled, Randomized, Double Blind, Cross-Over Trial of Gralise for the Treatment of Post Laminectomy Pain Syndrome
Phase of Trial: Phase IV
Latest Information Update: 01 Apr 2017
At a glance
- Drugs Gabapentin (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Acronyms GRASSP
- 24 Mar 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.
- 11 May 2016 Planned End Date changed from 1 Jun 2018 to 1 Dec 2019.
- 11 May 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.